Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening.

Pro-survival members of the Bcl-2 protein family inhibit cell death by binding short helical BH3 motifs in pro-apoptotic proteins. Mammalian pro-survival proteins Bcl-x(L), Bcl-2, Bcl-w, Mcl-1, and Bfl-1 bind with varying affinities and specificities to native BH3 motifs, engineered peptides, and small molecules. Biophysical studies have determined interaction patterns for these proteins, particularly for the most-studied family members Bcl-x(L) and Mcl-1. Bfl-1 is a pro-survival protein implicated in preventing apoptosis in leukemia, lymphoma, and melanoma. Although Bfl-1 is a promising therapeutic target, relatively little is known about its binding preferences. We explored the binding of Bfl-1 to BH3-like peptides by screening a peptide library that was designed to sample a high degree of relevant sequence diversity. Screening using yeast-surface display led to several novel high-affinity Bfl-1 binders and to thousands of putative binders identified through deep sequencing. Further screening for specificity led to identification of a peptide that bound to Bfl-1 with K(d) < 1 nM and very slow dissociation from Bfl-1 compared to other pro-survival Bcl-2 family members. A point mutation in this sequence gave a peptide with ~50 nM affinity for Bfl-1 that was selective for Bfl-1 in equilibrium binding assays. Analysis of engineered Bfl-1 binders deepens our understanding of how the binding profiles of pro-survival proteins differ and may guide the development of targeted Bfl-1 inhibitors.

[1]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[2]  Liisa Holm,et al.  Dali server: conservation mapping in 3D , 2010, Nucleic Acids Res..

[3]  S. Tait,et al.  Bcl-2 Family Member Bfl-1/A1 Sequesters Truncated Bid to Inhibit Its Collaboration with Pro-apoptotic Bak or Bax* , 2002, The Journal of Biological Chemistry.

[4]  P. Marrack,et al.  The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. , 2003, Immunity.

[5]  Amy E Keating,et al.  Predictive Bcl-2 family binding models rooted in experiment or structure. , 2012, Journal of molecular biology.

[6]  Erinna F. Lee,et al.  High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL. , 2009, Angewandte Chemie.

[7]  J. Richardson,et al.  The penultimate rotamer library , 2000, Proteins.

[8]  Z. Ling,et al.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[9]  S. Richardson,et al.  Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands* , 2005, Journal of Biological Chemistry.

[10]  H. Varmus,et al.  MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family , 2009, Oncogene.

[11]  Gerhard Wagner,et al.  A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization. , 2004, Biochemistry.

[12]  Emiko Fire,et al.  Mcl‐1–Bim complexes accommodate surprising point mutations via minor structural changes , 2010, Protein science : a publication of the Protein Society.

[13]  W. Zong,et al.  Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist , 2008, Oncogene.

[14]  M. Berger,et al.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.

[15]  R. Rosenquist,et al.  Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia , 2007, British Journal of Cancer.

[16]  S. Eschrich,et al.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis , 2008, BMC Medical Genomics.

[17]  Nir London,et al.  In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2. , 2012, Biochemistry.

[18]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[19]  Brian J. Smith,et al.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.

[20]  Suzanne Cory,et al.  The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.

[21]  K Dane Wittrup,et al.  Isolating and engineering human antibodies using yeast surface display , 2006, Nature Protocols.

[22]  K. Rajewsky,et al.  Efficiency of RNA Interference in the Mouse Hematopoietic System Varies between Cell Types and Developmental Stages , 2005, Molecular and Cellular Biology.

[23]  C. Berking,et al.  Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1 , 2012, PloS one.

[24]  M. Vogler,et al.  BCL2A1: the underdog in the BCL2 family , 2011, Cell Death and Differentiation.

[25]  Pär Nordlund,et al.  Completing the family portrait of the anti‐apoptotic Bcl‐2 proteins: Crystal structure of human Bfl‐1 in complex with Bim , 2008, FEBS letters.

[26]  Roberto Piva,et al.  Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. , 2006, The Journal of clinical investigation.

[27]  A. Keating,et al.  Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. , 2010, Journal of molecular biology.

[28]  C. Raymond,et al.  General method for plasmid construction using homologous recombination. , 1999, BioTechniques.

[29]  Chengyu Liang,et al.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX , 2011, Cell Research.

[30]  M. Bickle,et al.  Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein. , 2011, Biochemistry.

[31]  I. Brooks,et al.  Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. , 1993, Analytical biochemistry.

[32]  Lin Chen,et al.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.

[33]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[34]  M. Hinds,et al.  Structural plasticity underpins promiscuous binding of the prosurvival protein A1. , 2008, Structure.

[35]  A. Strasser,et al.  BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death , 2000, Cell.

[36]  C. Reynolds,et al.  Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy , 2009, Clinical Cancer Research.

[37]  C. Tse,et al.  ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. , 2008, Cancer research.

[38]  Catherine Charbonnel,et al.  Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen , 2008, Breast Cancer Research and Treatment.

[39]  Paul H. C. Eilers,et al.  Enhancing scatterplots with smoothed densities , 2004, Bioinform..

[40]  David W. Andrews,et al.  Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes , 2007, Apoptosis.

[41]  M. Lackmann,et al.  The structure of Bcl‐w reveals a role for the C‐terminal residues in modulating biological activity , 2003, The EMBO journal.

[42]  Patrick R. Cushing,et al.  The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling. , 2008, Biochemistry.

[43]  K Dane Wittrup,et al.  Yeast surface display for protein engineering and characterization , 2007, Current Opinion in Structural Biology.

[44]  J C Reed,et al.  Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins , 2006, Cell Death and Differentiation.

[45]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[46]  John Calvin Reed,et al.  Differential Regulation of Bax and Bak by Anti-apoptotic Bcl-2 Family Proteins Bcl-B and Mcl-1* , 2008, Journal of Biological Chemistry.

[47]  R. Copeland,et al.  Residence time of receptor-ligand complexes and its effect on biological function. , 2008, Biochemistry.

[48]  A. Keating,et al.  Structure-based redesign of the binding specificity of anti-apoptotic Bcl-x(L). , 2013, Journal of molecular biology.